Source link : https://newshealth.biz/health-news/does-elinzanetant-reduce-vms-in-younger-patients/
Another phase 3 trial has demonstrated the effectiveness of the dual-neurokinin receptor antagonist elinzanetant in controlling hot flashes in women on adjuvant endocrine therapy for hormone receptor-positive (HR+) breast cancer. This time, the sample included younger and older patients with less frequent and severe episodes than patients in the previously published trials had experienced. “Elinzanetant […]
The post Does Elinzanetant Reduce VMS in Younger Patients? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-27 08:21:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8